Activation of osmo-sensitive LRRC8 anion channels in macrophages is important for micro-crystallin joint inflammation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
18 Sep 2024
Historique:
received: 04 11 2023
accepted: 12 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 18 9 2024
Statut: epublish

Résumé

Deposition of monosodium urate and calcium pyrophosphate (MSU and CPP) micro-crystals is responsible for painful and recurrent inflammation flares in gout and chondrocalcinosis. In these pathologies, the inflammatory reactions are due to the activation of macrophages responsible for releasing various cytokines including IL-1β. The maturation of IL-1β is mediated by the multiprotein NLRP3 inflammasome. Here, we find that activation of the NLRP3 inflammasome by crystals and concomitant production of IL-1β depend on cell volume regulation via activation of the osmo-sensitive LRRC8 anion channels. Both pharmacological inhibition and genetic silencing of LRRC8 abolish NLRP3 inflammasome activation by crystals in vitro and in mouse models of crystal-induced inflammation. Activation of LRRC8 upon MSU/CPP crystal exposure induces ATP release, P2Y receptor activation and intracellular calcium increase necessary for NLRP3 inflammasome activation and IL-1β maturation. We identify a function of the LRRC8 osmo-sensitive anion channels with pathophysiological relevance in the context of joint crystal-induced inflammation.

Identifiants

pubmed: 39294178
doi: 10.1038/s41467-024-52543-8
pii: 10.1038/s41467-024-52543-8
doi:

Substances chimiques

NLR Family, Pyrin Domain-Containing 3 Protein 0
Inflammasomes 0
Interleukin-1beta 0
LRRC8A protein, mouse 0
Membrane Proteins 0
Uric Acid 268B43MJ25
LRRC8A protein, human 0
Nlrp3 protein, mouse 0
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8179

Subventions

Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-22-CE14-0020
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-22-CE14-0020
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-22-CE14-0020
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-22-CE14-0020

Informations de copyright

© 2024. The Author(s).

Références

Dalbeth, N., Gosling, A. L., Gaffo, A. & Abhishek, A. Gout. Lancet 397, 1843–1855 (2021).
pubmed: 33798500 doi: 10.1016/S0140-6736(21)00569-9
Doherty, M. et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet 392, 1403–1412 (2018).
pubmed: 30343856 pmcid: 6196879 doi: 10.1016/S0140-6736(18)32158-5
Latourte, A. et al. Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study. Ann. Rheum. Dis. 79, 1126–1128 (2020).
pubmed: 32213498 doi: 10.1136/annrheumdis-2020-217188
Martin, W. J., Walton, M. & Harper, J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal–induced murine peritoneal model of acute gout. Arthritis Rheumatism 60, 281–289 (2009).
pubmed: 19116939 doi: 10.1002/art.24185
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
pubmed: 16407889 doi: 10.1038/nature04516
Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407–420 (2016).
pubmed: 27291964 doi: 10.1038/nri.2016.58
Compan, V. et al. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37, 487–500 (2012).
pubmed: 22981536 doi: 10.1016/j.immuni.2012.06.013
Ip, W. K. E. & Medzhitov, R. Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation. Nat. Commun. 6, 6931 (2015).
pubmed: 25959047 doi: 10.1038/ncomms7931
Qiu, Z. et al. SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel. Cell 157, 447–458 (2014).
pubmed: 24725410 pmcid: 4023864 doi: 10.1016/j.cell.2014.03.024
Voss, F. K. et al. Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC. Science 344, 634–638 (2014).
pubmed: 24790029 doi: 10.1126/science.1252826
Lutter, D., Ullrich, F., Lueck, J. C., Kempa, S. & Jentsch, T. J. Selective transport of neurotransmitters and modulators by distinct volume-regulated LRRC8 anion channels. J. Cell Sci. 130, 1122–1133 (2017).
pubmed: 28193731 doi: 10.1242/jcs.196253
Syeda, R. et al. LRRC8 proteins form volume-regulated anion channels that sense ionic strength. Cell 164, 499–511 (2016).
pubmed: 26824658 pmcid: 4733249 doi: 10.1016/j.cell.2015.12.031
Takahashi, H., Yamada, T., Denton, J. S., Strange, K. & Karakas, E. Cryo-EM structures of an LRRC8 chimera with native functional properties reveal heptameric assembly. Elife 12, e82431 (2023).
pubmed: 36897307 pmcid: 10049205 doi: 10.7554/eLife.82431
Liu, H. et al. Structural insights into anion selectivity and activation mechanism of LRRC8 volume-regulated anion channels. Cell Rep. 42, 112926 (2023).
pubmed: 37543949 pmcid: 10480491 doi: 10.1016/j.celrep.2023.112926
Green, J. P. et al. LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation. Elife 9, e59704 (2020).
pubmed: 33216713 pmcid: 7679132 doi: 10.7554/eLife.59704
Renaudin, F. et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages. Ann. Rheum. Dis. 79, 1506–1514 (2020).
pubmed: 32699039 doi: 10.1136/annrheumdis-2020-217342
Edwards, J. C., Sedgwick, A. D. & Willoughby, D. A. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134, 147–156 (1981).
pubmed: 7019400 doi: 10.1002/path.1711340205
Campillo-Gimenez, L. et al. Inflammatory potential of four different phases of calcium pyrophosphate relies on NF-κB Activation and MAPK Pathways. Front Immunol. 9, 2248 (2018).
pubmed: 30356764 pmcid: 6189479 doi: 10.3389/fimmu.2018.02248
Savage, D. F. & Stroud, R. M. Structural basis of aquaporin inhibition by mercury. J. Mol. Biol. 368, 607–617 (2007).
pubmed: 17376483 pmcid: 3535476 doi: 10.1016/j.jmb.2007.02.070
Friard, J. et al. Comparative effects of chloride channel inhibitors on LRRC8/VRAC-mediated chloride conductance. Front. Pharmacol. 8, 328 (2017).
Decher, N. et al. DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration. Br. J. Pharm. 134, 1467–1479 (2001).
doi: 10.1038/sj.bjp.0704413
Lück, J. C., Puchkov, D., Ullrich, F. & Jentsch, T. J. LRRC8/VRAC anion channels are required for late stages of spermatid development in mice. J. Biol. Chem. 293, 11796–11808 (2018).
pubmed: 29880644 pmcid: 6066314 doi: 10.1074/jbc.RA118.003853
Stuhlmann, T., Planells-Cases, R. & Jentsch, T. J. LRRC8/VRAC anion channels enhance β-cell glucose sensing and insulin secretion. Nat. Commun. 9, 1974 (2018).
pubmed: 29773801 pmcid: 5958052 doi: 10.1038/s41467-018-04353-y
Riteau, N. et al. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 3, e403 (2012).
pubmed: 23059822 pmcid: 3481132 doi: 10.1038/cddis.2012.144
Ollivier, M. et al. P2X-GCaMPs as versatile tools for imaging extracellular ATP signaling. eNeuro 8, ENEURO.0185-20.2020 (2021).
Murakami, T. et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl Acad. Sci. 109, 11282–11287 (2012).
pubmed: 22733741 pmcid: 3396518 doi: 10.1073/pnas.1117765109
Hoffmann, E. K., Lambert, I. H. & Pedersen, S. F. Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89, 193–277 (2009).
pubmed: 19126758 doi: 10.1152/physrev.00037.2007
Jentsch, T. J. VRACs and other ion channels and transporters in the regulation of cell volume and beyond. Nat. Rev. Mol. Cell Biol. 17, 293–307 (2016).
pubmed: 27033257 doi: 10.1038/nrm.2016.29
Shanfield, S., Campbell, P., Baumgarten, M., Bloebaum, R. & Sarmiento, A. Synovial fluid osmolality in osteoarthritis and rheumatoid arthritis. Clin. Orthop. Relat. Res. 235, 289–295 (1988).
Bertram, K. L. & Krawetz, R. J. Osmolarity regulates chondrogenic differentiation potential of synovial fluid derived mesenchymal progenitor cells. Biochem Biophys. Res Commun. 422, 455–461 (2012).
pubmed: 22579684 doi: 10.1016/j.bbrc.2012.05.015
Petroni, R. C. et al. Hypertonic saline (NaCl 7.5%) reduces lps-induced acute lung injury in rats. Inflammation 38, 2026–2035 (2015).
pubmed: 25962375 doi: 10.1007/s10753-015-0183-4
Schreibman, D. L. et al. Mannitol and hypertonic saline reduce swelling and modulate inflammatory markers in a rat model of intracerebral hemorrhage. Neurocrit Care 29, 253–263 (2018).
pubmed: 29700692 pmcid: 6202189 doi: 10.1007/s12028-018-0535-7
Schorn, C. et al. Sodium overload and water influx activate the NALP3 inflammasome. J. Biol. Chem. 286, 35–41 (2011).
pubmed: 21051542 doi: 10.1074/jbc.M110.139048
Rabolli, V. et al. Critical role of aquaporins in interleukin 1β (IL-1β)-induced inflammation. J. Biol. Chem. 289, 13937–13947 (2014).
pubmed: 24700466 pmcid: 4022865 doi: 10.1074/jbc.M113.534594
da Silva, I. V. et al. Aquaporin-3 is involved in NLRP3-inflammasome activation contributing to the setting of inflammatory response. Cell Mol. Life Sci. 78, 3073–3085 (2021).
pubmed: 33231721 doi: 10.1007/s00018-020-03708-3
Burow, P., Klapperstück, M. & Markwardt, F. Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages. Pflug. Arch. 467, 1215–1226 (2015).
doi: 10.1007/s00424-014-1561-8
Tang, T. et al. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat. Commun. 8, 202 (2017).
pubmed: 28779175 pmcid: 5544706 doi: 10.1038/s41467-017-00227-x
Domingo-Fernández, R., Coll, R. C., Kearney, J., Breit, S. & O’Neill, L. A. J. The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1β transcription and activate the NLRP3 inflammasome. J. Biol. Chem. 292, 12077–12087 (2017).
pubmed: 28576828 pmcid: 5519359 doi: 10.1074/jbc.M117.797126
Friard, J. et al. LRRC8/VRAC channels exhibit a noncanonical permeability to glutathione, which modulates epithelial-to-mesenchymal transition (EMT). Cell Death Dis 10, 925 (2019).
Zhou, C. et al. Transfer of cGAMP into bystander cells via LRRC8 volume-regulated anion channels augments sting-mediated interferon responses and anti-viral immunity. Immunity 52, 767–781.e6 (2020).
pubmed: 32277911 doi: 10.1016/j.immuni.2020.03.016
Hyzinski-García, M. C., Rudkouskaya, A. & Mongin, A. A. LRRC8A protein is indispensable for swelling-activated and ATP-induced release of excitatory amino acids in rat astrocytes. J. Physiol. 592, 4855–4862 (2014).
pubmed: 25172945 pmcid: 4259531 doi: 10.1113/jphysiol.2014.278887
Gaitán-Peñas, H. et al. Investigation of LRRC8-mediated volume-regulated anion currents in xenopus oocytes. Biophys. J. 111, 1429–1443 (2016).
pubmed: 27705766 pmcid: 5052465 doi: 10.1016/j.bpj.2016.08.030
Ferrari, D. et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451–1458 (1997).
pubmed: 9233643 doi: 10.4049/jimmunol.159.3.1451
Di Virgilio, F. Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol. Sci. 28, 465–472 (2007).
pubmed: 17692395 doi: 10.1016/j.tips.2007.07.002
Baron, L. et al. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death Dis. 6, e1629 (2015).
pubmed: 25654762 pmcid: 4669808 doi: 10.1038/cddis.2014.576
Sil, P. et al. P2Y6 receptor antagonist MRS2578 inhibits neutrophil activation and aggregated neutrophil extracellular trap formation induced by gout-associated monosodium urate crystals. J. Immunol. 198, 428–442 (2017).
pubmed: 27903742 doi: 10.4049/jimmunol.1600766
Uratsuji, H. et al. P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J. Immunol. 188, 436–444 (2012).
pubmed: 22102722 doi: 10.4049/jimmunol.1003746
Lee, G.-S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492, 123–127 (2012).
pubmed: 23143333 pmcid: 4175565 doi: 10.1038/nature11588
Triantafilou, K., Hughes, T. R., Triantafilou, M. & Morgan, B. P. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J. Cell Sci. 126, 2903–2913 (2013).
pubmed: 23613465
Gong, T., Yang, Y., Jin, T., Jiang, W. & Zhou, R. Orchestration of NLRP3 inflammasome activation by ion fluxes. Trends Immunol. 39, 393–406 (2018).
pubmed: 29452983 doi: 10.1016/j.it.2018.01.009
Yaron, J. R. et al. K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis. 6, e1954–e1954 (2015).
pubmed: 26512962 pmcid: 5399176 doi: 10.1038/cddis.2015.277
Camello-Almaraz, C., Gomez-Pinilla, P. J., Pozo, M. J. & Camello, P. J. Mitochondrial reactive oxygen species and Ca2+ signaling. Am. J. Physiol.-Cell Physiol. 291, C1082–C1088 (2006).
pubmed: 16760264 doi: 10.1152/ajpcell.00217.2006
Duranton, C., Huber, S. M. & Lang, F. Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J. Physiol. 539, 847–855 (2002).
pubmed: 11897854 pmcid: 2290198 doi: 10.1113/jphysiol.2001.013040
Capó-Aponte, J. E., Iserovich, P. & Reinach, P. S. Characterization of regulatory volume behavior by fluorescence quenching in human corneal epithelial cells. J. Membr. Biol. 207, 11–22 (2005).
pubmed: 16463139 doi: 10.1007/s00232-005-0800-5
Untergasser, A. et al. Primer3–new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).
pubmed: 22730293 pmcid: 3424584 doi: 10.1093/nar/gks596

Auteurs

Twinu Wilson Chirayath (TW)

Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France.

Matthias Ollivier (M)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.

Mete Kayatekin (M)

Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.
Université Côte d'Azur, CNRS, LP2M, Nice, France.

Isabelle Rubera (I)

Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.
Université Côte d'Azur, CNRS, LP2M, Nice, France.

Chinh Nghia Pham (CN)

Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France.

Jonas Friard (J)

Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.
Université Côte d'Azur, CNRS, LP2M, Nice, France.

Nathalie Linck (N)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.

Hélene Hirbec (H)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.

Christèle Combes (C)

Université Toulouse, ENSACIET, INPT-CNRS, F-31000, Toulouse, France.

Mylène Zarka (M)

Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France.

Frédéric Lioté (F)

Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France.
Hôpital Lariboisière, AP-HP, Rheumatology department, Centre Viggo Petersen, DMU Locomoteur, Paris, France.

Pascal Richette (P)

Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France.
Hôpital Lariboisière, AP-HP, Rheumatology department, Centre Viggo Petersen, DMU Locomoteur, Paris, France.

Francois Rassendren (F)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France.

Vincent Compan (V)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094, Montpellier, France. vincent.compan@igf.cnrs.fr.
Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France. vincent.compan@igf.cnrs.fr.

Christophe Duranton (C)

Laboratory of Excellence Ion Channels, Science & Therapeutics, F-06560, Valbonne, France. christophe.duranton@univ-cotedazur.fr.
Université Côte d'Azur, CNRS, LP2M, Nice, France. christophe.duranton@univ-cotedazur.fr.

Hang Korng Ea (HK)

Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France. hang-korng.ea@aphp.fr.
Hôpital Lariboisière, AP-HP, Rheumatology department, Centre Viggo Petersen, DMU Locomoteur, Paris, France. hang-korng.ea@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH